IMPLICATION OF THE GPIIB-296-306 SEQUENCE IN THE LIGAND-BINDING FUNCTION OF GPIIB-IIIA

被引:0
|
作者
DSOUZA, S [1 ]
GINSBERG, MH [1 ]
PLOW, EF [1 ]
机构
[1] Scripps Res Inst, RES INST, COMM VASC BIOL, LA JOLLA, CA 92037 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:827 / 827
页数:1
相关论文
共 50 条
  • [22] A NOVEL MECHANISM FOR EXPOSURE OF FIBRINOGEN BINDING-SITES ON GPIIB-IIIA BY A MONOCLONAL-ANTIBODY
    HATO, T
    WATANABE, A
    NAKATANI, S
    MINAMOTO, Y
    FUJITA, S
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (01) : 138 - 143
  • [23] Maintenance of the GPIIb-IIIa activation state supporting "irreversible" fibrinogen binding is energy dependent.
    Peerschke, EIB
    BLOOD, 1998, 92 (10) : 350A - 350A
  • [24] Platelet HDL3 binding sites are not related to integrin αIIbβ3 (GPIIb-IIIa)
    Pedreño, J
    de Castellarnau, C
    Masana, L
    ATHEROSCLEROSIS, 2001, 154 (01) : 23 - 29
  • [25] A new method of measurement of the binding of purified GPIIb-IIIa to plasma and recombinant von Willebrand factor
    Veyradier, A
    Obert, B
    Houllier, A
    Ribba, AS
    Meyer, D
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2578 - P2578
  • [26] ALTERATIONS OF HIGH AND LOW-AFFINITY CONFORMATIONS OF GPIIB-IIIA AS A RESULT OF LIGAND-RECEPTOR INTERACTION
    HEATH, TL
    WALL, CD
    JENNINGS, LK
    BLOOD, 1993, 82 (10) : A75 - A75
  • [27] Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic autoimmune thrombocytopenic purpura recognizing epitopes in very close proximity to the ligand-binding site of GPIIb.
    Kosugi, S
    Tomiyama, Y
    Honda, S
    Kashiwagi, H
    Kato, H
    Kiyoi, T
    Kurata, Y
    Matsuzawa, Y
    BLOOD, 2000, 96 (11) : 248A - 248A
  • [28] Flowcytometric measurement of fibrinogen binding in the presence of YM337, a chimeric antibody against GPIIb-IIIa
    Westrup, D
    Lorenz, M
    Müller, M
    Harder, S
    Breddin, HK
    Kirchmaier, CM
    THROMBOSIS AND HAEMOSTASIS, 1999, : 194 - 194
  • [29] Dissociation of GPIIb-IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation.
    Frelinger, AL
    Furman, MI
    Krueger, LA
    Barnard, MR
    Michelson, AD
    BLOOD, 1999, 94 (10) : 21A - 21A
  • [30] Measurement of ligand induced binding site expression in the presence of GPIIb/IIIa inhibitors.
    Jeske, WP
    Walenga, JM
    Leya, F
    Fareed, J
    BLOOD, 2001, 98 (11) : 44B - 44B